NM_145054.5:c.199G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_145054.5(CFAP52):c.199G>A(p.Val67Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_145054.5 missense
Scores
Clinical Significance
Conservation
Publications
- situs inversusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- visceral heterotaxyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151794Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251360 AF XY: 0.0000663 show subpopulations
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461836Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727218 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151912Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74214 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Situs inversus Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces valine with isoleucine at codon 67 of the CFAP52 protein (p.Val67Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs201479202, ExAC 0.06%). This variant has not been reported in the literature in individuals with CFAP52-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at